Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 1960584, 13 pages
https://doi.org/10.1155/2017/1960584
Research Article

Involvement of Normalized Glial Fibrillary Acidic Protein Expression in the Hippocampi in Antidepressant-Like Effects of Xiaoyaosan on Chronically Stressed Mice

1School of Basic Medical Science, Beijing University of Chinese Medicine, Beijing 100029, China
2Henan University of Chinese Medicine, Henan, China
3School of Pre-Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, China
4Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
5School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China

Correspondence should be addressed to Jia-Xu Chen; moc.liamtoh@uxaijnehc and Zhi-Ping Lv; moc.621@14284pzl

Received 15 August 2016; Revised 29 November 2016; Accepted 26 December 2016; Published 2 March 2017

Academic Editor: Junqing Yang

Copyright © 2017 Xiu-Fang Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Yao, H.-Y. Huang, Y.-X. Yang, and J.-Y. Guo, “Cinnamic aldehyde treatment alleviates chronic unexpected stress-induced depressive-like behaviors via targeting cyclooxygenase-2 in mid-aged rats,” Journal of Ethnopharmacology, vol. 162, pp. 97–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Araya-Callís, C. Hiemke, N. Abumaria, and G. Flugge, “Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus,” Psychopharmacology, vol. 224, no. 1, pp. 209–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Czéh, T. Michaelis, T. Watanabe et al., “Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12796–12801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Alfonso, G. D. Pollevick, M. G. Van Der Hart, G. Flügge, E. Fuchs, and A. C. C. Frasch, “Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus,” European Journal of Neuroscience, vol. 19, no. 3, pp. 659–666, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Cooper, E. Fuchs, and G. Flügge, “Expression of the axonal membrane glycoprotein M6a is regulated by chronic stress,” PLoS ONE, vol. 4, no. 1, article e3659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Czéh, M. Simon, B. Schmelting, C. Hiemke, and E. Fuchs, “Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment,” Neuropsychopharmacology, vol. 31, no. 8, pp. 1616–1626, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-X. Chen, W. Li, X. Zhao, and J.-X. Yang, “Effects of the Chinese traditional prescription Xiaoyaosan decoction on chronic immobilization stress-induced changes in behavior and brain BDNF, TrkB, and NT-3 in rats,” Cellular and Molecular Neurobiology, vol. 28, no. 5, pp. 745–755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. X.-F. Ding, X.-H. Zhao, Y. Tao et al., “Xiao Yao San improves depressive-like behaviors in rats with chronic immobilization stress through modulation of locus coeruleus-norepinephrine system,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 605914, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Liu, Y. Zhang, M. Han et al., “Chinese herbal formula XIAO YAO SAN for treatment of depression: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 931636, 13 pages, 2012. View at Publisher · View at Google Scholar
  10. Y. Chen, J. Liu, X. Wu, and E. C. Nice, “Xiangshao granule exerts antidepressive effects in a depression mouse model by ameliorating deficits in hippocampal BDNF and TrkB,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 309262, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Y. Zhu, Q.-Q. Mao, S.-P. Ip et al., “A standardized Chinese herbal decoction, kai-xin-san, restores decreased levels of neurotransmitters and neurotrophic factors in the brain of chronic stress-induced depressive rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 149256, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Zheng, R. Li, H. Shi et al., “Exploring the potential therapeutic mechanism of Xiao-Yao-San for major depression,” in Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine (IEEE BIBM '14), pp. 229–234, Belfast, UK, November 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-X. Wang, J.-X. Chen, G.-X. Yue, M.-H. Bai, M.-J. Kou, and Z.-Y. Jin, “Xiaoyaosan decoction regulates changes in neuropeptide y and leptin receptor in the rat arcuate nucleus after chronic immobilization stress,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 381278, 16 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhu, O. Xia, W. Han et al., “Xiao Yao San improves depressive-like behavior in rats through modulation of β-arrestin 2-mediated pathways in hippocampus,” Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID 902516, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. X. Zhu, L. Jing, C. Chen et al., “Danzhi Xiaoyao San ameliorates depressive-like behavior by shifting toward serotonin via the downregulation of hippocampal indoleamine 2,3-dioxygenase,” Journal of Ethnopharmacology, vol. 160, pp. 86–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Li, X.-D. Tang, Z.-X. Cai et al., “CNP signal pathway up-regulated in rectum of depressed rats and the interventional effect of Xiaoyaosan,” World Journal of Gastroenterology, vol. 21, no. 5, pp. 1518–1530, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Cao, L.-P. Li, Q. Wang et al., “Astrocyte-derived ATP modulates depressive-like behaviors,” Nature Medicine, vol. 19, no. 6, pp. 773–777, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Strekalova, N. Gorenkova, E. Schunk, O. Dolgov, and D. Bartsch, “Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress,” Behavioural Pharmacology, vol. 17, no. 3, pp. 271–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. S. Kirshenbaum, K. Saltzman, B. Rose, J. Petersen, B. Vilsen, and J. C. Roder, “Decreased neuronal na+,K+-ATPase activity in atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress,” Genes, Brain and Behavior, vol. 10, no. 5, pp. 542–550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Pothion, J.-C. Bizot, F. Trovero, and C. Belzung, “Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress,” Behavioural Brain Research, vol. 155, no. 1, pp. 135–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhu, J. Wang, Y. Zhang et al., “Unpredictable chronic mild stress induces anxiety and depression-like behaviors and inactivates AMP-activated protein kinase in mice,” Brain Research, vol. 1576, no. 1, pp. 81–90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Iijima, K. Fukumoto, and S. Chaki, “Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test,” Behavioural Brain Research, vol. 235, no. 2, pp. 287–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. H. Denenberg, “Open‐field behavior in the rat: what DOES it mean?” Annals of the New York Academy of Sciences, vol. 159, no. 3, pp. 852–859, 1969. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Stanford, “The open field test: reinventing the wheel,” Journal of Psychopharmacology, vol. 21, no. 2, pp. 134–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. S. Duman and B. Voleti, “Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents,” Trends in Neurosciences, vol. 35, no. 1, pp. 47–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Mullen, C. R. Buck, and A. M. Smith, “Neun, a neuronal specific nuclear protein in vertebrates,” Development, vol. 116, no. 1, pp. 201–211, 1992. View at Google Scholar · View at Scopus
  27. J. Lee, W. Duan, and M. P. Mattson, “Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice,” Journal of Neurochemistry, vol. 82, no. 6, pp. 1367–1375, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Masashi, S. Morinobu, and S. R. Duman, “Regulation of BDNF and TRKB MRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments,” The Journal of Neuroscience, vol. 15, no. 11, pp. 7539–7547, 1995. View at Google Scholar
  29. B. A. Samuels and R. Hen, “Neurogenesis and affective disorders,” European Journal of Neuroscience, vol. 33, no. 6, pp. 1152–1159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. David, B. A. Samuels, Q. Rainer et al., “Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression,” Neuron, vol. 62, no. 4, pp. 479–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Santarelli, M. Saxe, C. Gross et al., “Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants,” Science, vol. 301, no. 5634, pp. 805–809, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Castrén and T. Rantamäki, “The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity,” Developmental Neurobiology, vol. 70, no. 5, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Zhang, J. Li, and W. Sha, “Neurotrophic factors and major depressive disorder,” in Major Depressive Disorder—Cognitive and Neurobiological Mechanisms, chapter 2, 2015. View at Publisher · View at Google Scholar
  34. F. Karege, M. Schwald, and M. Cisse, “Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets,” Neuroscience Letters, vol. 328, no. 3, pp. 261–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Airaksinen and M. Saarma, “The GDNF family: signalling, biological functions and therapeutic value,” Nature Reviews Neuroscience, vol. 3, no. 5, pp. 383–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. R. S. Duman and L. M. Monteggia, “A neurotrophic model for stress-related mood disorders,” Biological Psychiatry, vol. 59, no. 12, pp. 1116–1127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. B. S. Diniz, A. L. Teixeira, A. S. Miranda, L. L. Talib, W. F. Gattaz, and O. V. Forlenza, “Circulating Glial-derived neurotrophic factor is reduced in late-life depression,” Journal of Psychiatric Research, vol. 46, no. 1, pp. 135–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Wang, Z. Hou, Y. Yuan et al., “Association study between plasma GDNF and cognitive function in late-onset depression,” Journal of Affective Disorders, vol. 132, no. 3, pp. 418–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. I. G. Barbosa, R. B. Huguet, L. P. Sousa et al., “Circulating levels of GDNF in bipolar disorder,” Neuroscience Letters, vol. 502, no. 2, pp. 103–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. X. B. Zhang, J. Li, W. Sha et al., “Neurotrophic factors and major depressive disorder,” in Major Depressive Disorder—Cognitive and Neurobiological Mechanisms, InTech, 2015. View at Publisher · View at Google Scholar
  41. R. J. Mullen, C. R. Buck, and A. M. Smith, “NeuN, a neuronal specific nuclear protein in vertebrates,” Development, vol. 116, no. 1, pp. 201–211, 1992. View at Google Scholar · View at Scopus
  42. V. V. Gusel'nikova and D. Korzhevskiy, “NEUN as a neuronal nuclear antigen and neuron differentiation marker,” ACTA Naturae, vol. 7, no. 2, p. 42, 2015. View at Google Scholar
  43. M. A. Davoli, J. Fourtounis, J. Tam et al., “Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat,” Neuroscience, vol. 115, no. 1, pp. 125–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. C.-C. Shen, Y.-C. Yang, M.-T. Chiao, W.-Y. Cheng, Y.-S. Tsuei, and J.-L. Ko, “Characterization of endogenous neural progenitor cells after experimental ischemic stroke,” Current Neurovascular Research, vol. 7, no. 1, pp. 6–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. W.-X. Liu, J. Wang, Z.-M. Xie et al., “Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression,” Psychopharmacology, vol. 233, no. 3, pp. 405–415, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Wang, J. Qiao, Y. Zhang et al., “Desvenlafaxine prevents white matter injury and improves the decreased phosphorylation of the rate-limiting enzyme of cholesterol synthesis in a chronic mouse model of depression,” Journal of Neurochemistry, vol. 131, no. 2, pp. 229–238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Kettenmann and B. R. Ranson, Neuroglia, Oxford University Press, New York, NY, USA, 2nd edition, 2005.
  48. D. K. Cullen, C. M. Simon, and M. C. LaPlaca, “Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal–astrocytic co-cultures,” Brain Research, vol. 1158, pp. 103–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Simard, G. Arcuino, T. Takano, Q. S. Liu, and M. Nedergaard, “Signaling at the gliovascular interface,” The Journal of Neuroscience, vol. 23, no. 27, pp. 9254–9262, 2003. View at Google Scholar · View at Scopus
  50. M. V. Sofroniew and H. V. Vinters, “Astrocytes: biology and pathology,” Acta Neuropathologica, vol. 119, no. 1, pp. 7–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Nedergaard, B. Ransom, and S. A. Goldman, “New roles for astrocytes: Redefining the functional architecture of the brain,” Trends in Neurosciences, vol. 26, no. 10, pp. 523–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Rajkowska and C. A. Stockmeier, “Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue,” Current Drug Targets, vol. 14, no. 11, pp. 1225–1236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Ding, X. Zhang, H. Guo et al., “The functional study of a Chinese herbal compounded antidepressant medicine—jie yu chu fan capsule on chronic unpredictable mild stress mouse model,” PLoS ONE, vol. 10, no. 7, Article ID e0133405, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Dutta, S. McKie, and J. F. W. Deakin, “Ketamine and other potential glutamate antidepressants,” Psychiatry Research, vol. 225, no. 1-2, pp. 1–13, 2015. View at Publisher · View at Google Scholar · View at Scopus